Clinical trials sponsored by Tongji Hospital

Phase breakdown

Conditions studied

Recruiting trials led by Tongji Hospital

• A Prospective Observational Study of First-Line Systemic Therapy Combined With Celiac Plexus Blockade for Advanced Biliopancreatic Cancer With Pain
  NCT07326137 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• A Real-world Study of Staging and Grading of Clinical Immune Status in Chronic Hepatitis B
  NCT06525909 · Phase: Not specified · Ages: 18 Years to 50 Years · Sex: All (male and female) · 5 locations
• AI-Based Prediction of Liver Metastasis in Colorectal Cancer (A Retrospective Study)
  NCT07399236 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• An In-situ Detection for MicroRNA
  NCT06529614 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Biomarkers in Autoimmune Disease of Nervous System
  NCT06502015 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Transplant Participants
  NCT07350837 · Phase: Early Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases
  NCT07337785 · Phase: Early Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Comparing Laparoscopic and Open Surgery for Pancreatic Carcinoma
  NCT03785743 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Effects of Ciprofol on Myocardial Injury After Non-cardiac Surgery in Video-Assisted Thoracoscopic Surgery
  NCT07028593 · Phase: Phase 4 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 1 location
• Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease
  NCT07077486 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD)
  NCT06474520 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Equecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE)
  NCT06902844 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer
  NCT05541367 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Fecal Microbiota Transplantation as the First-line Treatment in Active Pediatric Crohn's Disease
  NCT05321758 · Phase: Not applicable (e.g. observational or device study) · Ages: 2 Years to 16 Years · Sex: All (male and female) · 1 location
• Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
  NCT04561557 · Phase: Early Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease
  NCT06497387 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease
  NCT06497361 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Safety and Efficacy of Telitacicept in the Treatment of Systemic Lupus Erythematosus (SLE)
  NCT06458972 · Phase: Not specified · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.
  NCT07526493 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Safety of Etomidate-propofol Mixture vs. Propofol for Total Intravenous Anesthesia in Elderly Patients Undergoing Abdominal Surgery
  NCT07019246 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years to 80 Years · Sex: All (male and female) · 1 location
• Somatostatin Plus Clear Liquid Diet Versus Diverting Stoma in Patients With Rectal Cancer Undergoing Ultra-Low Anterior Resection
  NCT07605611 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 3 locations
• The Application of an AI-driven Multimodal Predictive Model for Cognitive Impairment in Patients With Type 2 Diabetes Mellitus
  NCT07128186 · Phase: Not specified · Ages: 40 Years to 75 Years · Sex: All (male and female) · 21 locations
• To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease
  NCT07149571 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases
  NCT07339540 · Phase: Early Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Tongji Hospital recruiting for?

Tongji Hospital is the lead sponsor of 24 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.